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Mindfulness-based Cognitive Therapy for 
Generalised Anxiety Disorder: a Systematic 
Review and Meta-analysis
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Abstract
Background: Generalised anxiety disorder (GAD) has harmful effects on physical and mental health and 
quality of life. Mindfulness-based cognitive therapy (MBCT) is a treatment option for GAD. This meta-
analysis was conducted to determine the effectiveness of MBCT on GAD. 
Methods: Two authors independently performed the eligibility, quality assessment, and data extraction 
processes, and consensus was reached in case of discrepancies. Electronic databases were searched 
for eligible studies (randomised controlled trials, randomised trials, cluster randomised controlled 
trials, and clinical trials) up to November 2018 using keywords: mindfulness-based cognitive therapy 
OR mindfulness based cognitive therapy OR MBCT AND general anxiety disorder OR GAD*. The 
methodological quality of studies was assessed using the revised Jadad scale. Cohen’s formula was used 
to determine the effect size based on the mean and standard deviation of the changes in the study groups 
before and after the intervention. 
Results: Six studies that compared the effectiveness between MBCT and controls were included for 
analysis. The mean revised Jadad score of the six studies was 4.3 (range, 3-6). The overall mean effect 
size was -0.65. The funnel plot of effect sizes in relation to the effect size standard error showed a 
symmetrical distribution. Compared with controls, MBCT significantly improved the treatment outcome 
of GAD in all studies, except one.
Conclusion: MBCT was effective for treating GAD. 
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Introduction
Generalised anxiety disorder (GAD) is characterised by 
extreme and uncontrollable worries and is associated with 
other anxiety disorders, depression, and a range of physical 
health disorders.1 GAD often occurs in early adulthood 
and is twice as likely to occur in women as in men.2 The 
prevalence of GAD in the Iranian population aged 18 to 
65 years is 2.5%3 and 0.6% to 4.3% in other countries. 
The risk of its lifetime prevalence is 9%.4 GAD has more 
harmful effects than other anxiety disorders on physical 
and mental health and quality of life.5,6 All these disorders 
use considerable healthcare services and cause functional 
disruptions.7
 Pharmacotherapy is the first treatment option.8,9 
However, it is associated with a relatively high rate of 
relapse and uncertain lasting effects after discontinuation of 
medication.10,11 Thus, psychological treatments are necessary.
 Mindfulness-based cognitive therapy (MBCT) can 
reduce general anxiety symptoms and anxiety sensitivity 
(the main components of GAD), with a specific mental 
orientation towards experience and awareness about the 
present time in a non-judgmental style by minimising the 
involvement in thoughts and feelings.12 MBCT is effective 
in treating patients with GAD.13 MBCT is an effective 
adjuvant to pharmacotherapy in patients with panic disorder 
or GAD.14 MBCT is more efficacious than a training 
programme for treating anxiety disorder.15 Therefore, we 
conducted a meta-analysis on the effectiveness of MBCT 
on GAD.
Methods
The PRISMA guideline for reporting systematic reviews 
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Results 
The flowchart for the inclusion process of studies is shown 
in Figure 1. The title and methodology of each eligible study 
were independently assessed. Of 203 papers evaluated, 
197 were excluded owing to repetition (n = 38), MBCT 
not being used or no inclusion criteria (n = 149), or not 
conducted specifically for GAD (n = 10). The remaining six 
studies that compared the effectiveness between MBCT and 
controls were included for analysis.14,15,17-20
 Among the six studies, the sample sizes ranged from 
11 to 182; the mean age of participants ranged from 32 to 
50 years; and percentage of women ranged from 0% to 79% 
(Table 1). The assessment tool used was the Beck Anxiety 
Index. The diagnosis of GAD was made according to the 
DSM-IV. The mean revised Jadad score of the six studies 
was 4.3 (range, 3-6) [Table 2]. 
 Effect sizes (Hedge’s g) and weights of six studies are 
shown in Figure 2. The overall sample size was 403. Effect 
sizes varied from -0.017 to -1.07, with an overall mean of 
-0.65 (95% confidence interval, -0.97 to -0.32; z = -3.93, 
p = 0.001). Heterogeneity was considerable (I2 = 49.96). 
This effect (d = 0.65) was significant (p < 0.001) and can 
be considered as a good effect indicating that the finding is 
robust. The fail-safe N analysis indicated that 14 missing 
equal sample size studies with no effect of MBCT compared 
and meta-analyses was used.16 Inclusion criteria for studies 
were: (1) randomised controlled trials, randomised trials, 
cluster randomised controlled trials, and clinical trials of 
MBCT for the treatment of GAD reported in English or 
Persian languages and published in peer-reviewed journals. 
(2) Participants aged ≥18 years diagnosed with GAD or 
GAD symptoms according to any diagnostic classification 
system who underwent MBCT, with anxiety scores 
measured according to a standard test.
 Two authors independently performed the eligibility, 
quality assessment, and data extraction processes, and 
consensus was reached in case of discrepancies. Electronic 
databases (PsycINFO, PubMed, Embase, ProQuest, 
Scopus, Web of Science, Google Scholar, and Medline) 
were searched for eligible studies up to November 2018 
using keywords: mindfulness-based cognitive therapy OR 
mindfulness based cognitive therapy OR MBCT AND 
general anxiety disorder OR GAD*. Papers in clinical 
psychology journals and other journals that had the most 
relevant early studies were also searched manually. 
In addition, reference lists of found articles and other 
reviews were inspected, and leading researchers in the 
field of MBCT were contacted to identify further relevant 
studies. Duplicates were removed from the total number 
of identified records. Abstracts from the remaining records 
were screened to retrieve full-text articles for assessment of 
eligibility. Studies fulfilling inclusion criteria were selected 
for meta-analytic evaluation. The retrieval process was 
checked by authors.
 A data extraction sheet was developed for participant 
characteristics (including age, sex, baseline anxiety 
score, and medication), group characteristics (including 
intervention, comparison condition, number of group 
participants and dropouts, and use of non-study treatments 
for anxiety within groups), and diagnosis and therapeutic 
characteristics (including diagnostic classification system, 
length of sessions and therapy period).
 The methodological quality of studies was assessed 
using the revised Jadad scale based on six criteria: (1) the 
study was described as randomised; (2) the randomisation 
procedure was described and appropriate, ie, study 
participants were randomly allocated independent of the 
investigators “by methods allowing each participant to 
have the same chance of receiving each intervention”; (3) 
blind outcome assessments were reported (blindness of 
participants and therapists, as required by the original Jadad 
criteria, are not possible); (4) the blinding method was 
appropriate, (5) the number and reasons of withdrawals and 
dropouts were provided for each group, and (6) there was a 
description of inclusion/exclusion criteria. One point was 
assigned for each of the six fulfilled criteria; the maximum 
Jadad score was 6. Disagreements between raters were 
resolved by discussion.
 Statistical analyses were conducted using the STATA 
(version 16). Forest plot statistics and a funnel plot of 
individual study effect sizes were used for detecting 
potential biases in the publication of study results. Figure 1.  Flowchart of the inclusion process of studies
Records identified through 
database searching 
(n = 203)










Full-text articles assessed 
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Table 2. Methodological quality of studies based on the revised Jadad score
Table 1. Characteristics of the six studies

































Hoge et al,17 2013 Yes Yes No Not described Yes Yes 3
Asmaee Majid  
et al,18 2012
Yes Yes No Not described Yes Yes 3
Evans et al,15 2008 Yes Yes No Not described Yes Yes 3
Kim et al,14 2009 Yes Yes Yes Not described Yes Yes 5
Wong et al,19 2016 Yes Yes Yes Yes Yes Yes 6
Hoge et al,20 2015 Yes Yes Yes Yes Yes Yes 6
Study Country No. of 
participants




Diagnosis criteria Assessment tool
Hoge et al,17 2013 USA 89 39 (≥18) 52 DSM-IV for generalised 
anxiety disorder (GAD)
Beck Anxiety Index
Asmaee Majid  
et al,18 2012
Iran 37 32 (≥18) 0 DSM-IV for GAD Beck Anxiety Index
Evans et al,15 2008 USA 11 49 (18-80) 66 DSM-IV for GAD Beck Anxiety Index
Kim et al,14 2009 Korea 46 39 (20-60) 58 DSM-IV for GAD or 
panic disorder
Beck Anxiety Index
Wong et al,19 2016 China 182 50 (21-65) 79 DSM-IV for GAD Beck Anxiety Index
Hoge et al,20 2015 USA 38 37 (≥18) 55 DSM-IV for GAD Beck Anxiety Index
Figure 2.  Comparison of effectiveness between mindfulness-based cognitive therapy (MBCT) and controls: a risk ratio 
of <1 indicates favouring MBCT, and >1 favouring controls
Treatment Control Hedges’s g Weight
Study N Mean SD N Mean SD with 95% CI (%)
Hoge et al,17 2013 48 9.10 7.11 41 11.30 5.65 -0.34 [-0.75, 0.08] 22.08
Asmaee Majid et al,18 2012 16 12.96 6.10 15 16.31 7.15 -0.49 [-1.19, 0.20] 13.29
Evans et al,15 2008 11 8.91 7.80 11 19.00 13.70 -0.87 [-1.71, -0.03] 10.31
Kim et al,14 2009 24 5.20 5.40 22 10.30 5.70 -0.90 [-1.50, -0.31] 15.88
Wong et al,19 2016 61 26.50 5.00 56 33.00 7.00 -1.07 [-1.45, -0.68] 23.29
Hoge et al,20 2015 19 10.60 8.10 19 11.80 5.80 -0.17 [-0.79, 0.46] 15.15
Overall -0.65 [-0.97, -0.32]
Heterogeneity: T2 = 0.08, I2 = 49.96%, H2 = 2.00
Test of θi = θj: Q(5) = 10.14, p = 0.07
Test of θ = O: z = -3.93, p = 0.00
Random-effects REML model
-1.5 -1 -0.5 0 0.5
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Figure 3.  Funnel plot of standard error by effect sizes 
for relative risk of relapse between mindfulness-based 
cognitive therapy (MBCT) and controls: there is no 
publication bias when individual study effect sizes (risk 
ratios) are symmetrically distributed around the overall 



















with controls (ie, a risk ratio of 1.0) would be needed 
to reduce the overall risk of relapse effect size to a non-
significant level (p > 0.05). The funnel plot of effect sizes in 
relation to the effect size standard error had a symmetrical 
distribution (Figure 3).
Discussion
In the present meta-analysis, the overall risk ratio for 
GAD in MBCT versus controls was 0.65, which indicates 
that MBCT is an effective intervention for GAD. The 
methodological quality of the six studies was high, with a 
mean revised Jadad score of 4.3. There was no evidence of 
publication bias according to tests of funnel plot. Fourteen 
missing studies of comparable sample size with an effect 
size of zero would be needed to nullify the result. Therefore, 
this meta-analysis is considered credible. Evidence of 
heterogeneity between individual studies can be neglected 
because of vast cultural differences between countries of 
studies.
 A study of the effect of MBCT on GAD reported 
significant improvement in pathological concerns, stress, 
quality of life, and a number of other symptoms that 
remained after treatment, although the effect size on the 
improvement of pathologic concerns was very small.21 In 
MBCT, owing to the awareness exercises and being in the 
moment as well as awareness of physical sensations and 
psychological sensations, participants realise that when 
they are anxious, their heart rate and respiration changes. 
By MBCT, participants focus their attention on their body 
and thus increase the awareness of the body, feelings, and 
thoughts associated with anxiety, which increases the sense 
of symptom controllability, leading to anxiety reduction. 
MBCT is effective in the treatment of GAD by integrating 
elements of philosophy, dialectics, mindfulness, acceptance, 
and communication, and taking advantage of mediating as 
a pivotal domain, as well as focusing on attention control in 
the treatment.22
 The present study has some limitations. The number 
of studies included was small. The quality and type of 
methodology of the studies differed. In some studies, the 
MBCT group was compared with the non-intervention 
group, whereas in other studies, the MBCT group was 
compared with other-treatment group. This complicated the 
analysis and limited the power of results.23 In addition, the 
present study did not report the required data in the studies. 
In case of no access to full paper, the abstracts of studies 
were excluded. There was no access to some information 
sources and some required papers.
Conclusion
MBCT was effective for treating GAD.
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